817 related articles for article (PubMed ID: 26986718)
1. Very Early versus Delayed Rehabilitation for Acute Ischemic Stroke Patients with Intravenous Recombinant Tissue Plasminogen Activator: A Nationwide Retrospective Cohort Study.
Momosaki R; Yasunaga H; Kakuda W; Matsui H; Fushimi K; Abo M
Cerebrovasc Dis; 2016; 42(1-2):41-8. PubMed ID: 26986718
[TBL] [Abstract][Full Text] [Related]
2. Real-World Outcomes of Acute Ischemic Stroke Treatment with Intravenous Recombinant Tissue Plasminogen Activator.
Betts KA; Hurley D; Song J; Sajeev G; Guo J; Du EX; Paschoalin M; Wu EQ
J Stroke Cerebrovasc Dis; 2017 Sep; 26(9):1996-2003. PubMed ID: 28689999
[TBL] [Abstract][Full Text] [Related]
3. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
Kono S; Deguchi K; Morimoto N; Kurata T; Deguchi S; Yamashita T; Ikeda Y; Matsuura T; Narai H; Omori N; Manabe Y; Yunoki T; Takao Y; Kawata S; Kashihara K; Abe K
J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of Nonagenarians with Acute Ischemic Stroke Treated with Intravenous Thrombolytics.
Behrouz R; Masjuán-Vallejo J; Vera R; Willey JZ; Zedet M; Moulin S; Cordonnier C; Klijn CJM; Kanselaar K; Dirks M; Silver B; Khan M; Azarpazhooh MR; Godoy DA; Roffe C; Paley L; Bray BD; Smith CJ; Di Napoli M;
J Stroke Cerebrovasc Dis; 2018 Jan; 27(1):246-256. PubMed ID: 28935502
[TBL] [Abstract][Full Text] [Related]
5. Is there a decreased risk of intracerebral hemorrhage and mortality in obese patients treated with intravenous thrombolysis in acute ischemic stroke?
Hassan AE; Chaudhry SA; Jani V; Grigoryan M; Khan AA; Adil MM; Qureshi AI
J Stroke Cerebrovasc Dis; 2013 May; 22(4):545-9. PubMed ID: 23453555
[TBL] [Abstract][Full Text] [Related]
6. Generalized Safety and Efficacy of Simplified Intravenous Thrombolysis Treatment (SMART) Criteria in Acute Ischemic Stroke: The MULTI SMART Study.
Sørensen SB; Barazangi N; Chen C; Wong C; Grosvenor D; Rose J; Bedenk A; Morrow M; McDermott D; Hove JD; Tong DC
J Stroke Cerebrovasc Dis; 2016 May; 25(5):1110-1118. PubMed ID: 26897101
[TBL] [Abstract][Full Text] [Related]
7. Fixed Dose IV rt-PA and Clinical Outcome in Ischemic Stroke Patients With Body Weight >100 kg: Pooled Data From 3 Randomized Clinical Trials.
Majidi S; Leon Guerrero CR; Burger KM; Sigounas D; Olan WJ; Qureshi AI
J Stroke Cerebrovasc Dis; 2018 Oct; 27(10):2843-2848. PubMed ID: 30076113
[TBL] [Abstract][Full Text] [Related]
8. Expanded Indication for Recombinant Tissue Plasminogen Activator from 3 to 4.5 h after Onset of Stroke in Japan.
Miyamoto Y; Aso S; Iwagami M; Morita K; Fushimi K; Hamasaki Y; Nangaku M; Doi K; Yasunaga H
J Stroke Cerebrovasc Dis; 2020 Dec; 29(12):105341. PubMed ID: 33039772
[TBL] [Abstract][Full Text] [Related]
9. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO
J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152
[TBL] [Abstract][Full Text] [Related]
10. Characteristics and outcome of patients with early complete neurological recovery after thrombolysis for acute ischemic stroke.
Blinzler C; Breuer L; Huttner HB; Schellinger PD; Schwab S; Köhrmann M
Cerebrovasc Dis; 2011; 31(2):185-90. PubMed ID: 21160181
[TBL] [Abstract][Full Text] [Related]
11. Intravenous Tissue Plasminogen Activator for Wake-Up Stroke: A Propensity Score-Matched Analysis.
Anaissie JE; Monlezun DJ; Siegler JE; Waring ED; Dowell LN; Samai AA; George AJ; Kimbrough T; Berthaud J; Martin-Schild S
J Stroke Cerebrovasc Dis; 2016 Nov; 25(11):2603-2609. PubMed ID: 27476340
[TBL] [Abstract][Full Text] [Related]
12. Correlation of Changes in Leukocytes Levels 24 Hours after Intravenous Thrombolysis With Prognosis in Patients With Acute Ischemic Stroke.
Chen J; Zhang Z; Chen L; Feng X; Hu W; Ge W; Li X; Jin P; Shao B
J Stroke Cerebrovasc Dis; 2018 Oct; 27(10):2857-2862. PubMed ID: 30064868
[TBL] [Abstract][Full Text] [Related]
13. High Plasma D-Dimer Indicates Unfavorable Outcome of Acute Ischemic Stroke Patients Receiving Intravenous Thrombolysis.
Hsu PJ; Chen CH; Yeh SJ; Tsai LK; Tang SC; Jeng JS
Cerebrovasc Dis; 2016; 42(1-2):117-21. PubMed ID: 27088493
[TBL] [Abstract][Full Text] [Related]
14. Low-Dose Tissue Plasminogen Activator in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.
Cheng JW; Zhang XJ; Cheng LS; Li GY; Zhang LJ; Ji KX; Zhao Q; Bai Y
J Stroke Cerebrovasc Dis; 2018 Feb; 27(2):381-390. PubMed ID: 29111341
[TBL] [Abstract][Full Text] [Related]
15. Renal impairment reduces the efficacy of thrombolytic therapy in acute ischemic stroke.
Power A; Epstein D; Cohen D; Bathula R; Devine J; Kar A; Taube D; Duncan N; Ames D
Cerebrovasc Dis; 2013; 35(1):45-52. PubMed ID: 23428996
[TBL] [Abstract][Full Text] [Related]
16. Wake-up stroke within 3 hours of symptom awareness: imaging and clinical features compared to standard recombinant tissue plasminogen activator treated stroke.
Roveri L; La Gioia S; Ghidinelli C; Anzalone N; De Filippis C; Comi G
J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):703-8. PubMed ID: 22133742
[TBL] [Abstract][Full Text] [Related]
17. Imaging negative stroke: diagnoses and outcomes in intravenous tissue plasminogen activator-treated patients.
Spokoyny I; Raman R; Ernstrom K; Meyer BC; Hemmen TM
J Stroke Cerebrovasc Dis; 2014; 23(5):1046-50. PubMed ID: 24103663
[TBL] [Abstract][Full Text] [Related]
18. Intravenous Thrombolysis for Acute Ischemic Stroke due to Cervical Internal Carotid Artery Occlusion.
Yeo LL; Kong WY; Paliwal P; Teoh HL; Seet RC; Soon D; Rathakrishnan R; Ong V; Lee TH; Wong HF; Chan BP; Leow WK; Yuan C; Ting E; Gopinathan A; Tan BY; Sharma VK
J Stroke Cerebrovasc Dis; 2016 Oct; 25(10):2423-9. PubMed ID: 27344361
[TBL] [Abstract][Full Text] [Related]
19. Safety Outcomes After Thrombolysis for Acute Ischemic Stroke in Patients With Recent Stroke.
Merkler AE; Salehi Omran S; Gialdini G; Lerario MP; Yaghi S; Elkind MSV; Navi BB
Stroke; 2017 Aug; 48(8):2282-2284. PubMed ID: 28679847
[TBL] [Abstract][Full Text] [Related]
20. Preceding Intravenous Thrombolysis in Patients Receiving Endovascular Therapy.
Park HK; Chung JW; Hong JH; Jang MU; Noh HD; Park JM; Kang K; Lee SJ; Ko Y; Kim JG; Cha JK; Kim DH; Nah HW; Han MK; Kim BJ; Park TH; Park SS; Lee KB; Lee J; Hong KS; Cho YJ; Lee BC; Yu KH; Oh MS; Cho KH; Kim JT; Kim DE; Ryu WS; Choi JC; Kim WJ; Shin DI; Yeo MJ; Sohn SI; Lee JS; Lee J; Yoon BW; Bae HJ
Cerebrovasc Dis; 2017; 44(1-2):51-58. PubMed ID: 28427054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
